XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 12,000 $ 1,999,000
Accounts receivable 15,000
Inventory 485,000
Current portion of notes receivable 199,000 184,000
Prepaid expenses and other current assets 206,000 265,000
Total current assets 917,000 2,448,000
Property, plant and equipment, net 13,000 17,000
Notes receivable 17,000
Other intangible assets, net 17,278,000 17,808,000
Total assets 18,208,000 20,290,000
Current liabilities:    
Accounts payable 576,000 713,000
Accrued expenses 336,000 194,000
Note payable, related party 22,881,000 8,878,000
Total current liabilities 23,793,000 9,785,000
Deferred tax liability, net 3,268,000 3,268,000
Total liabilities 27,061,000 13,053,000
Commitments and contingencies (Note 12)
Stockholders’ (deficit) equity    
Preferred stock, $0.001 par value; 100,000,000 shares authorized, 60,496,041 shares issued and outstanding (60,496,041 on December 31, 2024); Liquidation value $0.001 per share, 60,496,041 aggregate. 60,496,041 on December 31, 2024). 60,000 60,000
Common stock, $0.001 par value; 4,000,000,000 shares authorized, 12,185,412 shares issued and outstanding (11,503,955 on December 31, 2024) 12,000 11,000
Additional paid-in capital 42,871,000 41,857,000
Accumulated deficit (54,752,000) (37,669,000)
Total stockholders’ (deficit) equity of the Company (11,809,000) 4,259,000
Non-controlling interest in subsidiaries 2,956,000 2,978,000
Total stockholders’ (deficit) equity (8,853,000) 7,237,000
Total liabilities and stockholders’ (deficit) equity $ 18,208,000 $ 20,290,000